Lesa Sroufe & Co Sells 40 Shares of UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Lesa Sroufe & Co lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 3.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 1,230 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Lesa Sroufe & Co’s holdings in UnitedHealth Group were worth $383,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Plancorp LLC increased its position in shares of UnitedHealth Group by 13.8% in the 2nd quarter. Plancorp LLC now owns 9,530 shares of the healthcare conglomerate’s stock valued at $2,811,000 after buying an additional 1,158 shares in the last quarter. O Shares Investment Advisers LLC increased its position in shares of UnitedHealth Group by 13.0% in the 2nd quarter. O Shares Investment Advisers LLC now owns 41,058 shares of the healthcare conglomerate’s stock valued at $12,110,000 after buying an additional 4,728 shares in the last quarter. Aevitas Wealth Management Inc. increased its position in shares of UnitedHealth Group by 18.4% in the 3rd quarter. Aevitas Wealth Management Inc. now owns 2,280 shares of the healthcare conglomerate’s stock valued at $711,000 after buying an additional 354 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. increased its position in shares of UnitedHealth Group by 20.8% in the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 51,371 shares of the healthcare conglomerate’s stock valued at $15,152,000 after buying an additional 8,855 shares in the last quarter. Finally, LGT Capital Partners LTD. increased its position in shares of UnitedHealth Group by 27.6% in the 3rd quarter. LGT Capital Partners LTD. now owns 375,406 shares of the healthcare conglomerate’s stock valued at $117,040,000 after buying an additional 81,103 shares in the last quarter. Institutional investors and hedge funds own 86.39% of the company’s stock.

A number of analysts recently commented on the stock. Stephens upped their price objective on shares of UnitedHealth Group from $325.00 to $335.00 and gave the company an “overweight” rating in a research report on Thursday, July 16th. Oppenheimer upped their target price on shares of UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a research note on Thursday, October 15th. Morgan Stanley reaffirmed a “buy” rating and issued a $371.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 16th. Raymond James upped their target price on shares of UnitedHealth Group from $350.00 to $355.00 and gave the stock a “strong-buy” rating in a research note on Thursday, October 15th. Finally, Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $310.00 to $335.00 and gave the stock a “hold” rating in a research note on Thursday, October 15th. Five investment analysts have rated the stock with a hold rating, twenty have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $346.68.

NYSE:UNH traded down $7.54 during mid-day trading on Monday, hitting $323.06. The stock had a trading volume of 2,404,972 shares, compared to its average volume of 4,196,100. UnitedHealth Group Inc has a twelve month low of $187.72 and a twelve month high of $335.65. The stock has a market cap of $307.02 billion, a price-to-earnings ratio of 18.56, a PEG ratio of 1.53 and a beta of 0.68. The company’s 50 day simple moving average is $314.09 and its 200 day simple moving average is $302.05. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.84 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $65.12 billion during the quarter, compared to the consensus estimate of $63.97 billion. During the same period last year, the business posted $3.88 EPS. UnitedHealth Group’s revenue was up 7.9% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Inc will post 16.78 earnings per share for the current year.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $320.59, for a total value of $4,808,850.00. Following the transaction, the director now directly owns 159,215 shares of the company’s stock, valued at approximately $51,042,736.85. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Marianne D. Short sold 12,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the completion of the transaction, the executive vice president now directly owns 140,885 shares in the company, valued at $45,271,985.90. The disclosure for this sale can be found here. Insiders sold a total of 37,336 shares of company stock valued at $11,893,276 over the last quarter. 0.80% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: How to calculate compound interest

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.